The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
We are a biotechnology company specialising in molecular biotechnology applications. We are developing a DNA-based Biosensor System (DBS), which can be used in point-of-care diagnosis to develop a revolutionising solution. It can detect a virus at molecular level though a finger-sized device, with no need of any other equipment and skilled technicians. It dramatically enhances diagnosis sensitivity and convenience at low operational costs.
Point-of-care diagnosis is being recognised as an effective measure to screen infectious viruses such as the African Swine Fever Virus, which is a deadly virus and has been causing substantial economic damage to the livestock industry worldwide. However, existing point-of-care diagnosis solutions are not sensitive enough, while traditional high-sensitivity testing is time-consuming. As a result, diagnoses often fail to serve the purpose of prevention.
Our novel diagnosis solution using DNA-based Biosensor System (DBS) can solve the pain points of point-of-care diagnosis by delivering speedy diagnosis with much higher sensitivity at low operational costs. There is no need of other equipment or skilled labour to run the diagnosis. It can dramatically enhance the efficiency of virus screening to protect farms from infectious disease outbreaks.